Literature DB >> 27268907

Neglected filoviruses.

Robin Burk1,2, Laura Bollinger1, Joshua C Johnson1, Jiro Wada1, Sheli R Radoshitzky3, Gustavo Palacios3, Sina Bavari3, Peter B Jahrling2, Jens H Kuhn1.   

Abstract

Eight viruses are currently assigned to the family Filoviridae Marburg virus, Sudan virus and, in particular, Ebola virus have received the most attention both by researchers and the public from 1967 to 2013. During this period, natural human filovirus disease outbreaks occurred sporadically in Equatorial Africa and, despite high case-fatality rates, never included more than several dozen to a few hundred infections per outbreak. Research emphasis shifted almost exclusively to Ebola virus in 2014, when this virus was identified as the cause of an outbreak that has thus far involved more than 28 646 people and caused more than 11 323 deaths in Western Africa. Consequently, major efforts are currently underway to develop licensed medical countermeasures against Ebola virus infection. However, the ecology of and mechanisms behind Ebola virus emergence are as little understood as they are for all other filoviruses. Consequently, the possibility of the future occurrence of a large disease outbreak caused by other less characterized filoviruses (i.e. Bundibugyo virus, Lloviu virus, Ravn virus, Reston virus and Taï Forest virus) is impossible to rule out. Yet, for many of these viruses, not even rudimentary research tools are available, let alone medical countermeasures. This review summarizes the current knowledge on these less well-characterized filoviruses. Published by Oxford University Press on behalf of FEMS 2016. This work is written by (a) US Government employee(s) and is in the public domain in the US.

Entities:  

Keywords:  Ebola; Filoviridae; cuevavirus; ebolavirus; filovirus; marburgvirus

Mesh:

Year:  2016        PMID: 27268907      PMCID: PMC4931228          DOI: 10.1093/femsre/fuw010

Source DB:  PubMed          Journal:  FEMS Microbiol Rev        ISSN: 0168-6445            Impact factor:   16.408


  200 in total

1.  Immunoglobulin G enzyme-linked immunosorbent assay using truncated nucleoproteins of Reston Ebola virus.

Authors:  T Ikegami; M Saijo; M Niikura; M E Miranda; A B Calaor; M Hernandez; D L Manalo; I Kurane; Y Yoshikawa; S Morikawa
Journal:  Epidemiol Infect       Date:  2003-06       Impact factor: 2.451

2.  [On the etiology of an unknown human infection originating from monkeys].

Authors:  R Siegert; H L Shu; W Slenczka; D Peters; G Müller
Journal:  Dtsch Med Wochenschr       Date:  1967-12-22       Impact factor: 0.628

3.  Vervent monkey disease. Transmission to the hamster.

Authors:  D I Simpson
Journal:  Br J Exp Pathol       Date:  1969-08

4.  Development of a preventive vaccine for Ebola virus infection in primates.

Authors:  N J Sullivan; A Sanchez; P E Rollin; Z Y Yang; G J Nabel
Journal:  Nature       Date:  2000-11-30       Impact factor: 49.962

5.  Ebola virus infection in guinea pigs: presumable role of granulomatous inflammation in pathogenesis.

Authors:  E Ryabchikova; L Kolesnikova; M Smolina; V Tkachev; L Pereboeva; S Baranova; A Grazhdantseva; Y Rassadkin
Journal:  Arch Virol       Date:  1996       Impact factor: 2.574

6.  Fruit bats as reservoirs of Ebola virus.

Authors:  Eric M Leroy; Brice Kumulungui; Xavier Pourrut; Pierre Rouquet; Alexandre Hassanin; Philippe Yaba; André Délicat; Janusz T Paweska; Jean-Paul Gonzalez; Robert Swanepoel
Journal:  Nature       Date:  2005-12-01       Impact factor: 49.962

7.  Treatment of Ebola virus infection with a recombinant inhibitor of factor VIIa/tissue factor: a study in rhesus monkeys.

Authors:  Thomas W Geisbert; Lisa E Hensley; Peter B Jahrling; Tom Larsen; Joan B Geisbert; Jason Paragas; Howard A Young; Terry M Fredeking; William E Rote; George P Vlasuk
Journal:  Lancet       Date:  2003-12-13       Impact factor: 79.321

8.  Isolation and partial characterisation of a new strain of Ebola virus.

Authors:  B Le Guenno; P Formenty; P Formentry; M Wyers; P Gounon; F Walker; C Boesch
Journal:  Lancet       Date:  1995-05-20       Impact factor: 79.321

9.  Homologous and heterologous protection of nonhuman primates by Ebola and Sudan virus-like particles.

Authors:  Kelly L Warfield; John M Dye; Jay B Wells; Robert C Unfer; Frederick W Holtsberg; Sergey Shulenin; Hong Vu; Dana L Swenson; Sina Bavari; M Javad Aman
Journal:  PLoS One       Date:  2015-03-20       Impact factor: 3.240

10.  Filovirus RefSeq entries: evaluation and selection of filovirus type variants, type sequences, and names.

Authors:  Jens H Kuhn; Kristian G Andersen; Yīmíng Bào; Sina Bavari; Stephan Becker; Richard S Bennett; Nicholas H Bergman; Olga Blinkova; Steven Bradfute; J Rodney Brister; Alexander Bukreyev; Kartik Chandran; Alexander A Chepurnov; Robert A Davey; Ralf G Dietzgen; Norman A Doggett; Olga Dolnik; John M Dye; Sven Enterlein; Paul W Fenimore; Pierre Formenty; Alexander N Freiberg; Robert F Garry; Nicole L Garza; Stephen K Gire; Jean-Paul Gonzalez; Anthony Griffiths; Christian T Happi; Lisa E Hensley; Andrew S Herbert; Michael C Hevey; Thomas Hoenen; Anna N Honko; Georgy M Ignatyev; Peter B Jahrling; Joshua C Johnson; Karl M Johnson; Jason Kindrachuk; Hans-Dieter Klenk; Gary Kobinger; Tadeusz J Kochel; Matthew G Lackemeyer; Daniel F Lackner; Eric M Leroy; Mark S Lever; Elke Mühlberger; Sergey V Netesov; Gene G Olinger; Sunday A Omilabu; Gustavo Palacios; Rekha G Panchal; Daniel J Park; Jean L Patterson; Janusz T Paweska; Clarence J Peters; James Pettitt; Louise Pitt; Sheli R Radoshitzky; Elena I Ryabchikova; Erica Ollmann Saphire; Pardis C Sabeti; Rachel Sealfon; Aleksandr M Shestopalov; Sophie J Smither; Nancy J Sullivan; Robert Swanepoel; Ayato Takada; Jonathan S Towner; Guido van der Groen; Viktor E Volchkov; Valentina A Volchkova; Victoria Wahl-Jensen; Travis K Warren; Kelly L Warfield; Manfred Weidmann; Stuart T Nichol
Journal:  Viruses       Date:  2014-09-26       Impact factor: 5.048

View more
  44 in total

1.  Discovery of Adamantane Carboxamides as Ebola Virus Cell Entry and Glycoprotein Inhibitors.

Authors:  Michael B Plewe; Nadezda V Sokolova; Vidyasagar Reddy Gantla; Eric R Brown; Shibani Naik; Alexandra Fetsko; Donald D Lorimer; David M Dranow; Hayden Smutney; Jameson Bullen; Rana Sidhu; Arshil Master; Junru Wang; E Adam Kallel; Lihong Zhang; Birte Kalveram; Alexander N Freiberg; Greg Henkel; Ken McCormack
Journal:  ACS Med Chem Lett       Date:  2020-05-01       Impact factor: 4.345

2.  Regulation of VP30-Dependent Transcription by RNA Sequence and Structure in the Genomic Ebola Virus Promoter.

Authors:  Simone Bach; Jana-Christin Demper; Arnold Grünweller; Stephan Becker; Nadine Biedenkopf; Roland K Hartmann
Journal:  J Virol       Date:  2020-12-02       Impact factor: 5.103

3.  Non-neutralizing Antibodies from a Marburg Infection Survivor Mediate Protection by Fc-Effector Functions and by Enhancing Efficacy of Other Antibodies.

Authors:  Philipp A Ilinykh; Kai Huang; Rodrigo I Santos; Pavlo Gilchuk; Bronwyn M Gunn; Marcus M Karim; Jenny Liang; Mallorie E Fouch; Edgar Davidson; Diptiben V Parekh; James B Kimble; Colette A Pietzsch; Michelle Meyer; Natalia A Kuzmina; Larry Zeitlin; Erica Ollmann Saphire; Galit Alter; James E Crowe; Alexander Bukreyev
Journal:  Cell Host Microbe       Date:  2020-04-21       Impact factor: 21.023

4.  A Two-Antibody Pan-Ebolavirus Cocktail Confers Broad Therapeutic Protection in Ferrets and Nonhuman Primates.

Authors:  Zachary A Bornholdt; Andrew S Herbert; Chad E Mire; Shihua He; Robert W Cross; Anna Z Wec; Dafna M Abelson; Joan B Geisbert; Rebekah M James; Md Niaz Rahim; Wenjun Zhu; Viktoriya Borisevich; Logan Banadyga; Bronwyn M Gunn; Krystle N Agans; Ariel S Wirchnianski; Eileen Goodwin; Kevin Tierney; William S Shestowsky; Ognian Bohorov; Natasha Bohorova; Jesus Velasco; Eric Ailor; Do Kim; Michael H Pauly; Kevin J Whaley; Galit Alter; Laura M Walker; Kartik Chandran; Larry Zeitlin; Xiangguo Qiu; Thomas W Geisbert; John M Dye
Journal:  Cell Host Microbe       Date:  2019-01-09       Impact factor: 21.023

5.  Development of a Human Antibody Cocktail that Deploys Multiple Functions to Confer Pan-Ebolavirus Protection.

Authors:  Anna Z Wec; Zachary A Bornholdt; Shihua He; Andrew S Herbert; Eileen Goodwin; Ariel S Wirchnianski; Bronwyn M Gunn; Zirui Zhang; Wenjun Zhu; Guodong Liu; Dafna M Abelson; Crystal L Moyer; Rohit K Jangra; Rebekah M James; Russell R Bakken; Natasha Bohorova; Ognian Bohorov; Do H Kim; Michael H Pauly; Jesus Velasco; Robert H Bortz; Kevin J Whaley; Tracey Goldstein; Simon J Anthony; Galit Alter; Laura M Walker; John M Dye; Larry Zeitlin; Xiangguo Qiu; Kartik Chandran
Journal:  Cell Host Microbe       Date:  2019-01-09       Impact factor: 21.023

6.  Antibodies from a Human Survivor Define Sites of Vulnerability for Broad Protection against Ebolaviruses.

Authors:  Anna Z Wec; Andrew S Herbert; Charles D Murin; Elisabeth K Nyakatura; Dafna M Abelson; J Maximilian Fels; Shihua He; Rebekah M James; Marc-Antoine de La Vega; Wenjun Zhu; Russell R Bakken; Eileen Goodwin; Hannah L Turner; Rohit K Jangra; Larry Zeitlin; Xiangguo Qiu; Jonathan R Lai; Laura M Walker; Andrew B Ward; John M Dye; Kartik Chandran; Zachary A Bornholdt
Journal:  Cell       Date:  2017-05-18       Impact factor: 41.582

7.  Ebolavirus Chimerization for the Development of a Mouse Model for Screening of Bundibugyo-Specific Antibodies.

Authors:  Philipp A Ilinykh; Jessica Graber; Natalia A Kuzmina; Kai Huang; Thomas G Ksiazek; James E Crowe; Alexander Bukreyev
Journal:  J Infect Dis       Date:  2018-11-22       Impact factor: 5.226

8.  RNA secondary structure at the transcription start site influences EBOV transcription initiation and replication in a length- and stability-dependent manner.

Authors:  Simone Bach; Jana-Christin Demper; Nadine Biedenkopf; Stephan Becker; Roland K Hartmann
Journal:  RNA Biol       Date:  2020-10-22       Impact factor: 4.652

Review 9.  A Forgotten Episode of Marburg Virus Disease: Belgrade, Yugoslavia, 1967.

Authors:  Elizabeta S Ristanović; Nenad S Kokoškov; Ian Crozier; Jens H Kuhn; Ana S Gligić
Journal:  Microbiol Mol Biol Rev       Date:  2020-05-13       Impact factor: 11.056

10.  Design and evaluation of bi- and trispecific antibodies targeting multiple filovirus glycoproteins.

Authors:  Elisabeth K Nyakatura; Samantha E Zak; Anna Z Wec; Daniel Hofmann; Sergey Shulenin; Russell R Bakken; M Javad Aman; Kartik Chandran; John M Dye; Jonathan R Lai
Journal:  J Biol Chem       Date:  2018-03-02       Impact factor: 5.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.